Skip to main content

Vascular Disease and Hypertension

  • Chapter
  • First Online:
Secondary Hypertension
  • 771 Accesses

Abstract

Some of the secondary hypertension is caused by different types of vascular diseases. Systemic vasculitis (including Takayasu arteritis (TA), polyarteritis nodosa (PAN), and ANCA-associated vasculitis (AAV)), nutcracker phenomenon, and arteriovenous fistula are more common in clinic. The following is a summary of the above contents in order to improve the understanding of secondary hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Misra DP, Wakhlu A, Agarwal V, Danda D. Recent advances in the management of Takayasu arteritis. Int J Rheum Dis. 2019;22(Suppl 1):60–8.

    Article  CAS  Google Scholar 

  2. Kim ESH, Beckman J. Takayasu arteritis: challenges in diagnosis and management. Heart. 2018;104(7):558–65.

    Article  CAS  Google Scholar 

  3. Qi Y, Yang L, Zhang H, Liang E, Song L, Cai J, Jiang X, Zou Y, Qian H, Wu H, Zhou X, Hui R, Zheng D. The presentation and management of hypertension in a large cohort of Takayasu arteritis. ClinRheumatol. 2018;37(10):2781–8.

    Google Scholar 

  4. Lee GY, Jang SY, Ko SM, Kim EK, Lee SH, Han H, Choi SH, Kim YW, Choe YH, Kim DK. Cardiovascular manifestations of Takayasu arteritis and their relationship to the disease activity: analysis of 204 Korean patients at a single center. Int J Cardiol. 2012;159(1):14–20.

    Article  Google Scholar 

  5. Arend WP, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990;33(8):1129–34.

    Article  CAS  Google Scholar 

  6. Takahashi K, Oharaseki T, Yokouchi Y, et al. Overview of the 2012 revised international Chapel Hill consensus conference nomenclature of Vasculitides (CHCC2012). Nihon JinzoGakkai Shi. 2014;56(2):70–9.

    Google Scholar 

  7. Virgilio AD, Greco A, Magliulo G, et al. Polyarteritisnodosa: a contemporary overview. Autoimmun Rev. 2016;15(6):564–70.

    Article  Google Scholar 

  8. Fonseka CL, Galappaththi SR, Abeyaratne D, et al. A case of PolyarteritisNodosapresenting as rapidly progressing intermittent claudication of right leg. Case Rep Med. 2017;2017(1):4219718.

    PubMed  PubMed Central  Google Scholar 

  9. Topaloglu R, Kazık M, Saatci I, et al. An unusual presentation of classic polyarteritisnodosa in a child. PediatrNephrol. 2005;20(7):1011–5.

    Google Scholar 

  10. Maeda M, Kobayashi M, Okamoto S, et al. Clinical observation of 14 cases of childhood polyarteritisnodosa in Japan. PediatrInt. 2015;39(2):277–9.

    Google Scholar 

  11. Barlow EL, Seddon O, Healy B. PAN’s labyrinth: a multidisciplinary delayed diagnosis and patient's perspective. BMJ Case Rep. 2016;2016:bcr2015213495.

    Article  Google Scholar 

  12. Albert DA, Silverstein MD, Paunicka K, et al. The diagnosis of polyarteritisnodosa. II. Empirical verification of a decision analysis model. Arthritis Rheum. 2014;31(9):1128–34.

    Article  Google Scholar 

  13. Kumar A, Goel A, Lapsiwala M. Polyarteritisnodosa with a chronic relapsing course. Oxf Med Case Reports. 2016;2016(10):omw065.

    Article  Google Scholar 

  14. Pagnoux C, Seror R, Henegar C, et al. Clinical features and outcomes in 348 patients with polyarteritisnodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French vasculitis study group database. Arthritis Rheum. 2014;62(2):616–26.

    Article  Google Scholar 

  15. Sharma A, Pinto B, Dhooria A, et al. Polyarteritisnodosa in North India: clinical manifestations and outcomes. God Zb Med Fak Skopje. 2014;9:S12.

    Google Scholar 

  16. Human A, Pagnoux C. Diagnosis and management of ADA2 deficient polyarteritisnodosa. Int J Rheum Dis. 2019;22:69–77.

    Article  CAS  Google Scholar 

  17. Morgan AJ, Schwartz RA. Cutaneous polyarteritisnodosa: a comprehensive review. Int J Dermatol. 2010;49(7):750–6.

    Article  Google Scholar 

  18. Howard T, Ahmad K, Swanson JA, Misra S. Polyarteritisnodosa. Tech VascIntervRadiol. 2014;17:247–51.

    Google Scholar 

  19. Turska M, Paradaturska J. Cutaneous polyarteritisnodosa. WiadLek. 2018;71:73–7.

    Google Scholar 

  20. Feinstein J, Arroyo R. Successful treatment of childhood onset refractory polyarteritisnodosa with tumor necrosis factor alpha blockade. J ClinRheumatolPract Rep Rheum Musculoskelet Dis. 2005;11(4):219.

    Google Scholar 

  21. Rowaiye OO, Kusztal M, Klinger M. The kidneys and ANCA-associated vasculitis: from pathogenesis to diagnosis. Clin Kidney J. 2015;8(3):343–50.

    Article  Google Scholar 

  22. Schönermarck U, Gross WL, De GK. Treatment of ANCA-associated vasculitis. Nat Rev Nephrol. 2014;10(1):25–36.

    Article  Google Scholar 

  23. Lally L, Spiera R. Current therapies for ANCA-associated vasculitis. Annu Rev Med. 2015;66:227–40.

    Article  CAS  Google Scholar 

  24. Kallenberg CG. Pathogenesis of ANCA-associated vasculitis, an update. Autoimmun Rev. 2016;15(7):704–13.

    Article  Google Scholar 

  25. Bramlage CP, Kröplin J, Wallbach M, et al. Management of cardiovascular risk factors in patients with ANCA-associated vasculitis. J EvalClinPract. 2017;23(4):747–54.

    Google Scholar 

  26. Langford C. Clinical features and diagnosis of small-vessel vasculitis. Cleve Clin J Med. 2012;79:S3–7.

    Article  Google Scholar 

  27. Gapud EJ, Seo P, Antiochos B. ANCA-associated vasculitis pathogenesis: a commentary. CurrRheumatol Rep. 2017;19(4):15.

    Google Scholar 

  28. Tesar V, Hruskova Z. Limitations of standard immunosuppressive treatment in ANCA-associated vasculitis and lupus nephritis. Nephron ClinPract. 2014;128(3–4):205–15.

    Article  CAS  Google Scholar 

  29. Gulleroglu K, Gulleroglu B, Baskin E. Nutcracker syndrome. World J Nephrol. 2014;3(4):277–81.

    Article  Google Scholar 

  30. Shi Y, Yang H, Feng Z, Chen F, Zhang H, Wu Z. Evaluation of posterior nutcracker phenomenon using multisection spiral CT. ClinRadiol. 2018;73(12):1060.e9–1060.e16.

    CAS  Google Scholar 

  31. Yun SJ, Lee JM, Nam DH, Ryu JK, Lee SH. Discriminating renal nutcracker syndrome from asymptomatic nutcracker phenomenon using multidetector computed tomography. AbdomRadiol. 2016;41(8):1580–8.

    Google Scholar 

  32. Ananthan K, Onida S, Davies AH. Nutcracker syndrome: an update on current diagnostic criteria and management guidelines. Eur J VascEndovascSurg. 2017;53(6):886–94.

    CAS  Google Scholar 

  33. Al-Jaishi AA, Liu AR, Lok CE, Zhang JC, Moist LM. Complications of the arteriovenous fistula: a systematic review. J Am SocNephrol. 2017;28(6):1839–50.

    Google Scholar 

  34. Luehr A. Use of ultrasound guidance during cannulation of arteriovenous fistulas. NephrolNurs J. 2018;45(5):423–34.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Zhu, B., Zhu, Q. (2020). Vascular Disease and Hypertension. In: Li, N. (eds) Secondary Hypertension. Springer, Singapore. https://doi.org/10.1007/978-981-15-0591-1_8

Download citation

  • DOI: https://doi.org/10.1007/978-981-15-0591-1_8

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-15-0590-4

  • Online ISBN: 978-981-15-0591-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics